Kyoto global consensus report onHelicobacter pylorigastritis
Top Cited Papers
Open Access
- 17 July 2015
- Vol. 64 (9) , 1353-1367
- https://doi.org/10.1136/gutjnl-2015-309252
Abstract
Objective To present results of the Kyoto Global Consensus Meeting, which was convened to develop global consensus on (1) classification of chronic gastritis and duodenitis, (2) clinical distinction of dyspepsia caused by Helicobacter pylori from functional dyspepsia, (3) appropriate diagnostic assessment of gastritis and (4) when, whom and how to treat H. pylori gastritis. Design Twenty-three clinical questions addressing the above-mentioned four domains were drafted for which expert panels were asked to formulate relevant statements. A Delphi method using an anonymous electronic system was adopted to develop the consensus, the level of which was predefined as ≥80%. Final modifications of clinical questions and consensus were achieved at the face-to-face meeting in Kyoto. Results All 24 statements for 22 clinical questions after extensive modifications and omission of one clinical question were achieved with a consensus level of >80%. To better organise classification of gastritis and duodenitis based on aetiology, a new classification of gastritis and duodenitis is recommended for the 11th international classification. A new category of H. pylori-associated dyspepsia together with a diagnostic algorithm was proposed. The adoption of grading systems for gastric cancer risk stratification, and modern image-enhancing endoscopy for the diagnosis of gastritis, were recommended. Treatment to eradicate H. pylori infection before preneoplastic changes develop, if feasible, was recommended to minimise the risk of more serious complications of the infection. Conclusions A global consensus for gastritis was developed for the first time, which will be the basis for an international classification system and for further research on the subject.Keywords
This publication has 142 references indexed in Scilit:
- Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED)Endoscopy, 2011
- Carcinogenic bacterial pathogen Helicobacter pylori triggers DNA double-strand breaks and a DNA damage response in its host cellsProceedings of the National Academy of Sciences, 2011
- Narrow Band Imaging for the Detection of Gastric Intestinal Metaplasia and Dysplasia During Surveillance EndoscopyDigestive Diseases and Sciences, 2010
- Predictors of gastroduodenal erosions in patients taking low‐dose aspirinAlimentary Pharmacology & Therapeutics, 2009
- Review article: ‘true’ re‐infection of Helicobacter pylori after successful eradication – worldwide annual rates, risk factors and clinical implicationsAlimentary Pharmacology & Therapeutics, 2008
- Gastritis staging in clinical practice: the OLGA staging systemGut, 2007
- Gastric cancer screening using the serum pepsinogen test methodGastric Cancer, 2006
- Why does Japan have a high incidence of gastric cancer? Comparison of gastritis between UK and Japanese patientsGut, 2006
- Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspepticsBritish Journal of Cancer, 2003
- Helicobacter pyloriInfection and the Development of Gastric CancerNew England Journal of Medicine, 2001